A charge for changing your mind
The weight-loss category page states that a consultation fee applies only where the provider approves a care plan and the patient chooses not to proceed with medication. That is an unusual term to publish at all, and this roster has no field for it — it is recorded here in prose because a reader would want to know.
It is worth knowing before starting an intake, because it inverts the usual assumption. The risk is not that you will be declined; it is that you will be approved and then decide against it.
Three lanes, one price
The site names its own lanes — injectable, oral, microdose — which is more structure than most sellers give. On the pages we read, only the microdose lane carries a price, and its product card describes the product as low-dose semaglutide or tirzepatide, so the figure is not scoped to a molecule.
The same page states that the price stays the same regardless of dose and that shipping is included on all orders. A promotional discount also rides the category page, which means the first amount a new buyer is charged is not the published figure.
What is not there
No company is named on any page we read. No compounding pharmacy, no individual clinician and no service area is published either.
One measurement note for anyone checking this site themselves: a plausible-looking path on this host returns a 404 with a body of twenty-five thousand bytes. On this host, and on many like it, the status code is the only thing that separates a page that exists from one that does not.
Josie's published pricing
| Medication | Price | Verified |
|---|---|---|
| Glp-1 (compounded) | $189/mothe microdose lane, priced without the molecule being fixed: the card reads "Low-dose semaglutide or tirzepatide", so the figure covers either | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 198 providers reviewed here are paid partners today; the other 194 are not. See how this works.
See Josie's current price →Good fit if
- Readers who want to know what happens financially if they are approved and then decline.
- Women looking for a seller that structures its offer around a microdose lane rather than treating it as an afterthought.
- Buyers who want the price to stay flat as the dose changes.
Look elsewhere if
- Readers who need the injectable or oral lane priced; neither carries a figure on the pages we read.
- Anyone who needs to know which molecule they are buying at the published price.
- Buyers who want a named company, pharmacy or clinician.
- Readers who need a service-area list, or for whom an FDA warning letter is disqualifying.
How this review was verified
- Re-read the weight-loss category page, the article carrying the priced product card, the about page and a legal page on 7 September 2026, comparing requested to effective URLs and running a nonsense path against the host in the same run.
- Read the status code rather than the body size on every result, after recording that a plausible path on this host returns a large 404.
- Stored the microdose figure against the general GLP-1 category rather than a molecule, because the product card names either.
- Ran a widened corporate-suffix pattern across every cached body on the host, proved first against a page known to name a company; it returned nothing here.
- Screened the brand against FDA's live warning-letter datatable with a positive and a negative control in the same invocation, and re-fetched the letter to confirm its title matches the name, reference number and date.